Advertisement

Targeted Oncology

, Volume 13, Issue 5, pp 667–667 | Cite as

Correction to: Medical Treatment Options for Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer Suffering from Brain Metastases and/or Leptomeningeal Disease

  • Maximilian Hochmair
Correction

Correction to: Targeted Oncology (2018) 13:269–285

  https://doi.org/10.1007/s11523-018-0566-1

Enhanced digital features were retrospectively added to this article.

To view enhanced digital features for this article go to  https://doi.org/10.6084/m9.figshare.7094075.

Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright information

© The Author(s) 2018

Authors and Affiliations

  1. 1.Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for COPD and Respiratory EpidemiologyViennaAustria

Personalised recommendations